Drug treatment in out-of-hospital cardiac arrest: Does vascular access route matter?
28 Jan 2020
bởiJairia Dela Cruz
Lidocaine and amiodarone yield similar gains in survival when used to treat shock-refractory out-of-hospital cardiac arrest (OHCA) relative to placebo, along with a more favourable neurological outcome at hospital discharge when administered intravenously, as shown in a recent study. Conversely, these beneficial effects may not be observed when the drugs are given via the intraosseous route.